Neuromonics Tinnitus Treatment
Medical in Willoughby

Is a medical device company dedicated to helping people with its treatments for ringing in the ears, clinically obvious as tinnitus. Neuromonics manufactures and distributes the only FDA cleared, patented and clinically proven medical devices designed for long term, meaningful relief of tinnitus. Beginning with the labor of Paul Davis, Ch.D. inventor of the Neuromonics Tinnitus Treatment, and research and development since the early 1990s, Neuromonics has helped thousands of tinnitus sufferers around the world improve their quality of life and overcome the daily challenges associated with tinnitus. Neuromonics has experienced great triumph in helping veterans obtain relief from their tinnitus. Through research and awarded grants, Neuromonics has demonstrated effectiveness in its products and services. Previously, Adams served as senior vice president of storage sales and services for Sun Microsystems, and as president and senior vice president of Beginning Data Corporation, occupied in Denver. He also was chief operating officer of Western Union, later acquired by First Data. West, Chairman: With more than 25 years of experience in the medical device industry, Ron West is president of Go West Inc. a management consulting firm servicing the medical device Industry. He also serves on the board of the Deafness Research Foundation. His experience spans banking, lofty technology plastics, environmental, electronics and medical device industries in North America, Europe and Australia. Quinn has advised and mentored several companies in operational, strategic and financial matters. With 20 years’ experience in venture capital, business strategy and begin up company operations, she also serves on the board of ABS portfolio companies AirXpanders Inc. Endoluminal Sciences Pt Ltd. Proacta Inc. and Vivive Inc. and was the founding investor and chair of Pharmaxis Pt Ltd. She has held operating roles with hasty stage technology based companies in the United States and Australia, and was at a strategic management consultant with Brain Company. Duane Knight, Chief Financial OfficerChief Operating Officer: Duane brings a career background in financial management for both public and private companies, and specialty in the medical device manufacturing industry, to Neuromonics. ABS Venture Partners is an Australian based life science specialist venture capital steady with more than 400 million under management. With offices in Melbourne and Sydney, ABS has invested in more than 30 private and public companies. The steady invests in and helps construct life science companies that involve Australasian operations or technology on both sides of the Pacific. ABS team members take energetic roles at the board slick of their portfolio companies. Additionally, ABS brings a meaningful international network of corporate collaborators and investors to further the prospects of portfolio companies. The steady is an early stage, diversified fund manager, investing across both physical and life sciences. Innovation Capital invests in businesses based on innovative Australian technology and unique intellectual property that give global opportunities in the medical device, telecommunications, IT, engineering, orderly tech and bio tech sectors. Innovation Capital’s team comprises entrepreneurs and executives with special track records in founding and building technology aspiring businesses that have become leaders in their fields. The steady brings decades of authentic world entrepreneurial experience to the active, hand son support of its invested companies, helping manage risk, maximize investor returns and nurture the companies on their paths to becoming globally triumphant businesses.